Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy
-
Published:2024-03
Issue:
Volume:29
Page:100237
-
ISSN:2405-6324
-
Container-title:Technical Innovations & Patient Support in Radiation Oncology
-
language:en
-
Short-container-title:Technical Innovations & Patient Support in Radiation Oncology
Author:
Costa Paulo,
Vale Joana,
Fonseca Graça,
Costa Adelina,
Kos MichaelORCID
Reference31 articles.
1. Rawla Prashanth s.l. Epidemiology of prostate cancer. World J Oncol 2019; 10(2): 63–89.
2. Bolla M, Henry A, Mason M, Wiegeld Tsl. The role of radiotherapy in localised and locally advanced prostate cancer. Asian J Urol 2019;6(2): 153–161.
3. Markovina S, Meeks M, Badiyan S, Vetter B, Gay H, Paradis A, et al. Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: a propensity score-matched analysis Adv Radiat Oncol 2018;3(2): 190–6.
4. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. s.l. The Lancet Oncol 2007; 2007;8(6):475–487.
5. Glass AS, Cowan JE, Fuldeore MJ, et al. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era. s.l.: Urology 2013;82(1):60–5.